公司资料
Terns Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- TERN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
52.95 USD (+0.04%)
收盘价
最后更新: 2026年5月4日
6.12B USD
市值
股价为何变动
目前无法获取 TERN 的收盘价变动背景。
公司概览
业务概览
Terns Pharmaceuticals is a small-molecule biotech focused on oncology and metabolic disease opportunities. Its pipeline is built around targeted therapies with room for multiple shots on goal.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Terns sits in specialty biotechnology.
商业模式特征
The company depends on clinical proof-of-concept, dose selection, and whether its pipeline can generate differentiated value.
生物医药行业定位
Terns is a high-beta development name whose stock reacts quickly to early clinical and strategic updates.
未来催化剂
- Terns Pharmaceuticals's catalysts are TERN-601 in obesity and TERN-701 in CML, the two programs that most directly determine whether the company has a real differentiated future. The market will care about whether either asset can keep the story moving.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。